1. Dolutegravir—a review of the pharmacology, efficacy, and safety in the treatment of HIV;CE Kandel;Drug Des Devel Ther,2015
2. Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS;H Taha;Infect Drug Resist,2015
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. United States Department of Health and Human Services. Available: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf.
4. European AIDS Clinical Society. Guidelines 8.0. October 2015. Available: http://www.eacsociety.org/files/2015_eacsguidelines_8_0-english_rev-20160124.pdf.
5. British HIV Association (BHIVA). BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015. Available: http://www.bhiva.org/documents/Guidelines/Treatment/2015/2015-treatment-guidelines.pdf.